Novo Nordisk Pre-Tax Income 2010-2024 | NVO

Novo Nordisk pre-tax income for the twelve months ending September 30, 2024 was $17.364B, a 29.19% increase year-over-year.

  • Novo Nordisk annual pre-tax income for 2023 was $15.199B, a 55.42% increase from 2022.
  • Novo Nordisk annual pre-tax income for 2022 was $9.779B, a 4.04% increase from 2021.
  • Novo Nordisk annual pre-tax income for 2021 was $9.4B, a 15.48% increase from 2020.

Novo Nordisk Pre-Tax Income 2010-2024 | NVO

  • Novo Nordisk annual pre-tax income for 2023 was $15.199B, a 55.42% increase from 2022.
  • Novo Nordisk annual pre-tax income for 2022 was $9.779B, a 4.04% increase from 2021.
  • Novo Nordisk annual pre-tax income for 2021 was $9.4B, a 15.48% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$757B
Johnson & Johnson (JNJ)$377.3B
AbbVie (ABBV)$354.3B
Merck (MRK)$255.9B
Novartis AG (NVS)$218.9B
AstraZeneca (AZN)$200.6B
Pfizer (PFE)$155.6B
Sanofi (SNY)$131.3B
Innoviva (INVA)$1.3B